Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

A story about oxygen nanobubbles (RNS60) by Jorge H Ramirez (587826)

“…The chemical composition of RNS60 is water, sodium chloride (0.9%), and oxygen (55 ± ppm) but no active pharmacological principle.[1,2] Revalesio and several scientists have declared that these nanobubbles are stable in solution and can be safely administered to humans using enteral and parenteral dosage forms.[3]</p> <p>Different mechanisms of action have been attributed to RNS60 including effects on cell membrane ion channels,[4] modulation of the PI3k-AKT pathway,[5] and anti-inflammatory actions [1,2]. …”